Article citationsMore>>
Buse, J.B., Nauck, M., Forst, T., Sheu, W.H., Shenouda, S.K., Heilmann, C.R., Hoogwerf, B.J., Gao, A., Boardman, M.K., Fineman, M., Porter, L. and Schernthaner, G. (2013) Exenatide Once Weekly versus Liraglutide Once Daily in Patients with Type 2 Diabetes (DURATION-6): A Randomised, Open-Label Study. The Lancet, 381, 117-124.
https://doi.org/10.1016/S0140-6736(12)61267-7
has been cited by the following article:
-
TITLE:
Overview of Type 2 Diabetes Drugs on the Market
AUTHORS:
Yuxi Hu, Yongshou Chen
KEYWORDS:
Type 2 Diabetes Mellitus, Insulin, Sodium-Dependent Glucose Transporters 2, Glucagon-Like Peptide-1
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.8 No.8,
August
6,
2020
ABSTRACT: Type 2 Diabetes Mellitus (T2DM) is a systemic metabolic disorder with complex pathogenesis. In recent years, a variety of new T2DM drugs have emerged, such as sodium-dependent glucose transporters 2 (SGLT-2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors. As traditional medicines, insulin also has developed kinds of formulations such as quick-acting or premixed insulin. In addition, new treatment schedules combining multiple drugs are also fully explored. The efficacy, the administration, the mechanism, the safety and the price of these drugs are all different, providing patients with multiple options. This paper reviews the main types of type 2 diabetes drugs on the market and describes the mechanism of action. The representative type 2 diabetes treatment drugs are listed, and the advantages and disadvantages of these representative drugs are preliminarily evaluated. This information is reviewed to help doctors with clinical medication.
Related Articles:
-
Fiorenzo Santoleri, Paola Sorice, Ruggero Lasala, Alberto Costantini
-
Mark R. Burge, Eric R. Schroeder, Stephen Mitchell
-
Martine Claude Etoa Etoga, Estelle Amandine Well, Simeon Pierre Choukem, Mesmin Dehayem, Francine Mendane Mekobe, Anne Boli Ongmeb, Astasselbe Hadja Inna, Jean Claude Mbanya, Eugene Sobngwi
-
Alfonso López Ruiz, María Ángeles Núñez Sánchez, Noelia Victoria García-Talavera Espín, Amparo Meoro Avilés, Cristina del Peso Gilsanz, Ricardo Soriano Sánchez, María Teresa Gallego García, José Soriano Palao, María Dolores Ortuño, Sacramento Tomás Navarro, Collaborative Groups of the Diabetes and Obesity Unit of the Hospital Reina Sofía
-
María Angeles Ibañez Gil, Alfonso López Ruiz, Alicia Hernández Torres, Ana Belén Hernández Cascales, Pedro Pujante Alarcon, María Dolores Hellín Gil